AVN-101

• UNSPSC Description:

  AVN-101 free base is a multi-target drug candidate with the potential to inhibit central nervous system (CNS) diseases. AVN-101 free base exhibits high inhibitory activity on 5-HT7 receptors and also has certain activity on 5-HT6, 5-HT2A and 5-HT2C receptors. Due to its anxiolytic and antidepressant activities, AVN-101 free base is also expected to be used in diseases such as general anxiety disorder, depression, schizophrenia and multiple sclerosis[1].

• Target Antigen:

  5-HT Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/avn-101.html

• Smiles:

  CC1=CC2=C(N(CCC3=CC=CC=C3)C4=C2CN(C)CC4)C=C1

• Molecular Weight:

  304.43

• References & Citations:

  [1]AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1025725-91-0